Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

ASH 2019 | Women in myeloma #woMMen

Nina Shah • 7 Dec 2019
ASH 2019
Multiple Myeloma

Nina Shah, MD, University of California-San Francisco, San Francisco, CA, explains the importance of women hematologists on Twitter, in particular #woMMen. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

More from Nina Shah

Representation of women in hematology and oncology
2:07
Representation of women in hematology and oncology
Nina Shah • 15 Jun 2024
T-Cell Engagers: targets, challenges and opportunity
19:39
T-Cell Engagers: targets, challenges and opportunity
Nina Shah • 27 Mar 2022
NKTR-255 in multiple myeloma and NHL
1:28
NKTR-255 in multiple myeloma and NHL
Nina Shah • 10 Dec 2021
Reporting patient experiences during the KarMMa trial
2:15
Reporting patient experiences during the KarMMa trial
Nina Shah • 10 Dec 2021

Related Videos

Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
4:32
Updated results from the iMMagine-1 trial of anito-cel in R/R multiple myeloma
Nina Shah • 18 Dec 2025
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
3:36
Investigating AZD0120, a dual-targeting CAR-T product, in R/R myeloma: DURGA-1 preliminary results
Nina Shah • 7 Dec 2025
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Nina Shah • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Nina Shah • 15 Dec 2025
The content of VJHemOnc is intended for healthcare professionals